CORAL is an NIH-funded multicenter clinical trial of patients with atherosclerotic blockage of blood flow to the kidneys, which may be present in up to 3 million Americans. Find out more about characteristics of individuals with this condition, and where to get more information about participating in this important clinical trial.
CORAL is a clinical trial that will test the hypothesis that stenting atherosclerotic renal artery stenosis in patients with systolic hypertension reduces the incidence of cardiovascular and renal events.
The main goal of CORAL is to gain knowledge that may help future patients. This section addresses what you as a patient in the CORAL clinical trial should know. Educational materials are available as well as in-depth information on the CORAL clinical trial itself.
For more information, contact the Clinical Coordinating Center at 419-383-6297
Questions, Technical Issues?
Contact the Webmaster
Copyright © 2006 CORAL. All Rights Reserved.